SCHEMBL8286140

SCHEMBL8286140

COCCOc1nc(C)cc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.37
GSK3B P49841 3/20 0.37
GAA P10253 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
KCNJ5 P48544 1/20 0.36
KCNJ3 P48549 1/20 0.36
BTK Q06187 1/20 0.35
TSHR P16473 3/20 0.35
CYP1A2 P05177 3/20 0.35
CLK4 Q9HAZ1 3/20 0.35
CYP3A4 P08684 2/20 0.35
CDK4 P11802 1/20 0.35
CCND1 P24385 1/20 0.35
CCND2 P30279 1/20 0.35
CCND3 P30281 1/20 0.35
LMNA P02545 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HTT P42858 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286426 0.89 PDE11A (0.39) PDE11AGSK3BGAAHPGDMAPK1
SCHEMBL8286078 0.88 HTR6 (0.41) PDE11AGSK3BGAAHPGDMAPK1
SCHEMBL8286424 0.87 MAT2A (0.41) PDE11AGSK3BGAAHPGDMAPK1
SCHEMBL8286457 0.86 LMNA (0.38) PDE11AGSK3BGAAHPGDMAPK1
SCHEMBL8286144 0.86 HRH3 (0.40) PDE11A
SCHEMBL8286076 0.85 PDE11A (0.39) PDE11AGSK3BGAAHPGDMAPK1
SCHEMBL5872270 0.85 PDE11A (0.44) PDE11AGSK3BGAAHPGDMAPK1
SCHEMBL8286083 0.84 PDE11A (0.38) PDE11AGSK3BGAAHPGDMAPK1
SCHEMBL8286191 0.84 KCNH3 (0.37) PDE11AGAAHPGDMAPK1TSHR
SCHEMBL8286086 0.84 PDE11A (0.46) PDE11ALMNAALDH1A1SMN1; SMN2GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed